Trandolapril

Specifications

87679-37-6CAS Number

618-046-0EC Number

(2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acidIUPAC Name

C24H34N2O5Chemical Formula

430.5 g/molMolecular Weight

trandolapril; 87679-37-6; Mavik; Gopten; Odrik; Trandolaprilum [Latin]; RU 44570; RU-44570; Trandolaprilum; Udrik; DTXSID2023692; 1T0N3G9CRC; RU44570; NSC-758939; CHEBI:9649; DTXCID003692; (2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid; (2S,3aR,7aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester; Trandolaprilum (Latin); 1H-Indole-2-carboxylic acid, 1-((2S)-2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-, (2S,3aR,7aS)-; 1H-Indole-2-carboxylic acid, octahydro-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, (2S-(1(R*(R*)),2-alpha,3a-alpha,7a-beta))-; (2S,3aR,7aS)-1-((2S)-2-(((2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid; (2S,3aR,7aS)-1-[(S)-N-[(S)-1-Carboxy-3-phenylpropyl]alanyl]hexahydro-2-indolinecarboxylic acid, 1-ethyl ester; Trandolapril Tablets; 1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-1H-indol-2-carboxylic acid; RefChem:57068; C09AA10; (2S,3aR,7aS)-1-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl)octahydro-1H-indole-2-carboxylic acid; (2s,3ar,7as)-1-[(2s)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-1h-indole-2-carboxylic acid; NCGC00182079-02; Preran; Odric; (2S,3aR,7aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydro-1H-indole-2-carboxylic acid; C24H34N2O5; (2S)-1-[(2R)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid; (2S,3aR,7aS)-1-((S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)octahydro-1H-indole-2-carboxylic acid; (2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-Ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid; CAS-87679-37-6; CCRIS 6594; Mavik (TN); UNII-1T0N3G9CRC; Trandolapril [USP:INN:BAN]; Trandolapril CRS; NCGC00095153-01; Trandolapril; (2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]propanoyl]octahydro-1H-indole-2-carboxylic acid; Trandolapril (Standard); TRANDOLAPRIL [MI]; TRANDOLAPRIL [INN]; TRANDOLAPRIL [JAN]; CHEMBL1519; TRANDOLAPRIL [VANDF]; SCHEMBL16610; TRANDOLAPRIL [MART.]; BIDD:GT0804; TRANDOLAPRIL [USP-RS]; TRANDOLAPRIL [WHO-DD]; Trandolapril (JAN/USP/INN); GTPL6453; orb1301883; HSDB 8392; HY-B0592R; GLXC-24182; HMS3262J10; TRANDOLAPRIL [ORANGE BOOK]; TARKA COMPONENT TRANDOLAPRIL; TRANDOLAPRIL [EP MONOGRAPH]; HY-B0592; MSK10691; Tox21_111453; Tox21_113152; Tox21_500924; TRANDOLAPRIL [USP MONOGRAPH]; BDBM50369775; EBC-27075; s6468; AKOS015843316; AKOS015896050; CCG-222228; DB00519; FT28365; KS-1467; LP00924; NSC 758939; SDCCGSBI-0633768.P001; NCGC00182079-01; NCGC00182079-03; NCGC00182079-09; NCGC00261609-01; (2S,3aR,7aS)-1-(N-((1S)-1-((Ethyloxy)carbonyl)-3-phenylpropyl)-L-alanyl)octahydro-1H-indole-2-carboxylic Acid; NS00001070; T5329; Trandolapril, >=98% (HPLC), white powder; D00383; W18796; EN300-7481395; F862949; Q929420; SR-02000000917; SR-02000000917-2; BRD-K28550399-001-01-4; Trandolapril, European Pharmacopoeia (EP) Reference Standard; Trandolapril, United States Pharmacopeia (USP) Reference Standard; (2S,3aR,7aS)-1-{N-[(2S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl}octahydro-1H-indole-2-carboxylic acid; 1H-INDOLE-2-CARBOXYLIC ACID, OCTAHYDRO N-((2S)-1-ETHOXY-1-OXO-4-PHENYLBUTAN-2-YL)-1-ALANYL (2S,3AR,7AS)Synonyms